NEW YORK – A November trial date has been set for the New York insider trading trial of a former hedge fund portfolio manager for SAC Capital Advisors.
A federal judge in Manhattan scheduled Mathew Martoma's trial for Nov. 4.
Martoma is accused of earning $9 million in bonuses after persuading a medical professor to leak secret data from an Alzheimer's disease trial between 2006 and 2008.
The government has alleged that Martoma's inside information enabled other investment professionals to earn a quarter-billion dollars illegally.
Martoma has pleaded not guilty. He is free on bail. His lawyer, Richard Strassberg, declined to comment after Wednesday's hearing.